The decrease of mitochondrial NADH dehydrogenease and drug induced apoptosis in doxorubicin resistant A431 cells.

Area of Science:

• Cell Biology
• Molecular Oncology
• Biochemistry

Background:

• Doxorubicin (DOX) is a chemotherapy drug that induces apoptosis.
• Acquired resistance to DOX is a significant clinical challenge.
• Understanding resistance mechanisms is crucial for improving cancer therapy.

Purpose of the Study:

• To investigate the mechanisms of Doxorubicin resistance in A10A cells, a human squamous carcinoma cell line.
• To identify molecular factors contributing to reduced apoptosis and altered cellular responses to DOX.

Main Methods:

• Comparative analysis of apoptosis induction by DOX in parent A431 cells and DOX-resistant A10A cells.
• Assessment of reactive oxygen species (ROS) generation and mitochondrial depolarization.
• RT-PCR based differential display to identify differentially expressed genes.
• Sequence homology analysis of identified clones.

Main Results:

• A10A cells showed significantly less apoptosis following DOX treatment compared to parent cells.
• DOX-induced ROS formation and mitochondrial depolarization were less pronounced in A10A cells.
• Catalase partially reversed DOX effects, confirming ROS involvement in apoptosis.
• Differential display identified a down-regulated clone with homology to mitochondrial NADH dehydrogenase III (ND3) gene in A10A cells.

Conclusions:

• Reduced apoptosis and ROS generation contribute to DOX resistance in A10A cells.
• Down-regulation of the mitochondrial ND3 gene may be a key factor in DOX resistance.
• Targeting ND3 or related pathways could offer strategies to overcome DOX resistance.